Berkshire Hathaway Inc. vs Eli Lilly and Company
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Eli Lilly and Company (LLY) is "Tailwind" with +73.1% revenue growth. Both companies report in the Financials and Healthcare sectors.
| Metric | Berkshire Hathaway Inc. (BRK-B) | Eli Lilly and Company (LLY) |
|---|---|---|
| Operator Signal | Neutral | Tailwind |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $93.7B | $19.8B |
| Revenue Growth | 0.7% | 73.1%* |
| Latest EPS | N/A | $8.26 |
| EPS Growth | N/A | 672.0% |
| Sector | Financials | Healthcare |
| Quarters Tracked | 8 | 8 |
Berkshire Hathaway Inc. (BRK-B) carries a "Neutral" signal with +0.7% revenue growth, while Eli Lilly and Company (LLY) is "Tailwind" with +73.1% revenue growth. Both companies report in the Financials and Healthcare sectors.